Colchicine twice a day for hand osteoarthritis (COLOR): a double-blind, randomised, placebo-controlled trial

Overview of attention for article published in The Lancet Rheumatology, April 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

news: 5 news outlets
blogs: 1 blog

twitter: 57 X users

Readers on

mendeley: 43 Mendeley

So far, Altmetric has seen 70 X posts from 57 X users, with an upper bound of 245,161 followers.

Hand OA tx ✋🏽: Many high quality trials in the past year negative trials first: Colchicine COLOR - https://t.co/QGRf4g3UZp Topical betamethasone #OARSI2024

Lancet rheumatologyに報告されたものは，有効性は示せず． https://t.co/wF7SP0hV3j

En otro intento de reposicionar medicinas la colchicina no resultò en personas con osteoartritis dolorosa en mano (0,5 mg de colchicina dos veces al día durante 12 semanas):no alivia el dolor y da mas eventos adversos https://t.co/txuC4ZnGph #EULAR2023 …

RT @TheLancetRheum: .@AnnaDossing presenting the results of the COLOR trial at #EULAR2023 Colchicine twice day for 12 weeks did not reliev…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 66 additional X posts.